MXRA8 and kidney neoplasm: Similarly, by using RT-qPCR, seven kidney tumor patients were divided into MXRA8+/ZAP− (patient No. 1, 2, 6, and 7) or MXRA8+/ZAP+ (patient No. 3, 4, and 5) group (Fig. 6k).